Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse

Hsu, 2021, COVID-19 Among US dialysis patients: risk factors and outcomes from a national dialysis provider, Am J Kidney Dis, 77, 748, 10.1053/j.ajkd.2021.01.003 Hsu, 2022, Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients, Am J Kidney Dis, 79, 307, 10.1053/j.ajkd.2021.10.002 Garcia, 2022, COVID-19 Vaccine type and humoral immune response in patients receiving dialysis, J Am Soc Nephrol, 33, 33, 10.1681/ASN.2021070936 Hsu, 2022, Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months, Clin J Am Soc Nephrol, 17, 403, 10.2215/CJN.12250921 Anand, 2022, SARS-CoV-2 vaccine antibody response and breakthrough infection in patients receiving dialysis, Ann Intern Med, 175, 371, 10.7326/M21-4176 Berar-Yanay, 2021, Waning humoral response 3 to 6 months after vaccination with the SARS-COV-2 BNT162b2 mRNA vaccine in dialysis patients, J Clin Med, 11, 64 Hsu, 2022, Seroresponse to third doses of SARS-CoV-2 vaccine among patients receiving maintenance dialysis, Am J Kidney Dis, 80, 151, 10.1053/j.ajkd.2022.03.002 Longlune, 2021, High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients, Nephrol Dial Transplant, 36, 1704, 10.1093/ndt/gfab193 Boudhabhay, 2022, COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection, Nephrol Dial Transplant, 37, 1357, 10.1093/ndt/gfac016 Gilboa, 2023, Factors associated with protection from SARS-CoV-2 omicron variant infection and disease among vaccinated health care workers in Israel, JAMA Netw Open, 6, 10.1001/jamanetworkopen.2023.14757 Joung, 2022, Awareness of SARS-CoV-2 omicron variant infection among adults with recent COVID-19 seropositivity, JAMA Netw Open, 5, 10.1001/jamanetworkopen.2022.27241 Melin, 2022, A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients, Ups J Med Sci, 127, 10.48101/ujms.v127.8959 Einbinder, 2022, Humoral response and SARS-CoV-2 infection risk following the third and fourth doses of the BNT162b2 vaccine in dialysis patients, Am J Nephrol, 53, 586, 10.1159/000525309 Freeman, 2022, Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material, J Virol Methods, 300, 10.1016/j.jviromet.2021.114430 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Espi, 2022, A prospective observational study for justification, safety, and efficacy of a third dose of MRNA vaccine in patients receiving maintenance hemodialysis, Kidney Int, 101, 390, 10.1016/j.kint.2021.10.040 Caplin, 2021, Risk of COVID-19 disease, dialysis unit attributes, and infection control strategy among London in-center hemodialysis patients, Clin J Am Soc Nephrol, 16, 1237, 10.2215/CJN.03180321 Clarke, 2021, Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection, Kidney Int, 99, 1470, 10.1016/j.kint.2021.03.009 Cohen, 2021, Antibody status, disease history, and incidence of SARS-CoV-2 infection among patients on chronic dialysis, J Am Soc Nephrol, 32, 1880, 10.1681/ASN.2021030387 Hall, 2022, Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection, N Engl J Med, 386, 1207, 10.1056/NEJMoa2118691 Keehner, 2021, Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce, N Engl J Med, 385, 1330, 10.1056/NEJMc2112981 White, 2021, Incident SARS-CoV-2 infection among mRNA-vaccinated and unvaccinated nursing home residents, N Engl J Med, 385, 474, 10.1056/NEJMc2104849 Meller, 2022, Optimized infection control practices augment the robust protective effect of vaccination for ESRD patients during a hemodialysis facility SARS-CoV-2 outbreak, Am J Infect Control, 50, 1118, 10.1016/j.ajic.2022.06.025 Montez-Rath, 2022, SARS-CoV-2 Infection during the omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses, J Am Soc Nephrol, 33, 1832, 10.1681/ASN.2022040504 Quiroga, 2023, Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study, Nephrol Dial Transplant, 38, 969, 10.1093/ndt/gfac307 Affeldt, 2022, Immune response to third and fourth COVID-19 vaccination in hemodialysis patients and kidney transplant recipients, Viruses, 14, 2646, 10.3390/v14122646 Kanai, 2023, Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis, Clin Exp Nephrol, 27, 639, 10.1007/s10157-023-02342-0